Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
17 Oct 2024
Historique:
received: 20 05 2024
medline: 17 10 2024
pubmed: 17 10 2024
entrez: 17 10 2024
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2024.285893 PMID: 39415693
pubmed: 39415693
doi: 10.3324/haematol.2024.285893
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Malin Hultcrantz (M)

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. hultcram@mskcc.org.

David Kleinman (D)

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY.

Ravi Vij (R)

Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.

Fernando Escalante (F)

Hematology Department, University Hospital of Leon, Leon.

Michel Delforge (M)

Department of Hematology, Catholic University of Leuven, Leuven.

Nirali Kotowsky (N)

Value, Evidence and Outcomes, GSK, Upper Providence, PA.

Jacopo Bitetti (J)

Global Medical Affairs, GSK, Zug.

Natalie Boytsov (N)

Value, Evidence and Outcomes, GSK, Upper Providence, PA.

Leena Camadoo-O'Byrne (L)

Real World Study Delivery, GSK, Stevenage.

Lindsey Powers Happ (LP)

Real World Data Strategy and Partnerships, Value, Evidence and Outcomes, GSK, Collegeville, PA.

Guillaume Germain (G)

Groupe d'Analyse, Ltee., Montreal, Quebec.

Ana Urosevic (A)

Groupe d'Analyse, Ltee., Montreal, Quebec.

Malena Mahendran (M)

Groupe d'Analyse, Ltee., Montreal, Quebec.

Mei Sheng Duh (MS)

Analysis Group, Inc., Boston, MA.

Francois Laliberte (F)

Groupe d'Analyse, Ltee., Montreal, Quebec.

Michele Cavo (M)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seragnoli", Universita degli Studi di Bologna, Bologna.

Hans C Lee (HC)

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

Classifications MeSH